# Indomethacin

## Indoy 25mg

| 藥物代碼           | OINDO2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Inflammation, pain in the musculoskeletal system, swelling after dental surgery                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 副作用             | >10%:Headache (12% to 16%), Vomiting (<=12%), Postoperative hemorrhage (<=11%)1% to 10%:Presyncope (<=3%), syncope (<=2%), Dizziness (3% to 9%), depression (1% to 3%), drowsiness (1% to 3%), fatigue (1% to 3%), malaise (1% to 3%), vertigo (1% to 3%), Pruritus (1% to 4%), hyperhidrosis (2%), skin rash (1% to 2%), Hot flash (2%), Epigastric pain (3% to 9%), heartburn (3% to 9%), nausea (3% to 9%), dyspepsia (2% to 9%), constipation (?6%), abdominal distress (1% to 3%), abdominal pain (<3%), diarrhea (<3%), decreased appetite (>=2%), Tinnitus (>1%), Swelling (3%; postprocedural)                       |
| 禁忌               | 1. Disabled for active gastric ulcers; should also be used with caution in patients with past gastric ulcers.2. Patients with asthma caused by allergic to Aspirin are banned.3. Disabled for children under the age of fourteen; use caution for patients who are pregnant or breastfeeding.4. Patients with epilepsy, Parkinson's disease and mental illness should also pay attention to use.5. The drug was banned within 14 days after the Coronary artery bypass graft (CABG).                                                                                                                                         |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 孕期用藥建議       | Human data suggest risk in 1st and 3rd trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 附帶說明           | Indomethacin use during the latter part of pregnancy may cause severe fetal toxicity. Short-term use, such as 24–48 hours, lessens the risk. Based on animal data, prostaglandin synthesis inhibitors, including indomethacin, might block blastocyst implantation. Nonsteroidal anti-inflammatory agents (NSAIDs) also have been associated with spontaneous abortions (SABs) and congenital malformations, but the absolute risk appears to be low. [20201124非類固醇消炎藥品安全資訊風險溝通表] 懷孕20週以上孕婦使用NSAIDs可能會導致胎兒腎功能障礙並導致羊水過少； 妊娠30週以上之孕婦可能導致胎兒動脈導管過早閉合的風險。 |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 注射劑給藥建議途徑 | PC, PO, WM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

